Page last updated: 2024-10-28

fasudil and Dyslipidemia

fasudil has been researched along with Dyslipidemia in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research Excerpts

ExcerptRelevanceReference
"Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia."7.81Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015)
"Present study was conducted to investigate the effects of rosuvastatin combined with fasudil on rabbits with dyslipidemia."3.81Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia. ( Li, Z; Lian, H; Liang, Q; Zeng, F; Zheng, D, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Z1
Lian, H1
Liang, Q1
Zeng, F1
Zheng, D1

Other Studies

1 other study available for fasudil and Dyslipidemia

ArticleYear
Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia.
    Lipids in health and disease, 2015, May-28, Volume: 14

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Drug Therapy, Combination; Dyslipidemias; Ma

2015